Speech digital biomarker combined with fluid biomarkers can predict Alzheimer’s type cognitive impairment through machine learning

Abstract

Background: Current methods for the early detection of Alzheimer's disease (AD) are constrained by high costs, invasiveness, and limited accessibility, underscoring the urgent need for alternative approaches that are accessible, affordable, and patient‐friendly.

The paper